Amwill Health Care Ltd Stock Price Today (NSE: AMWILL)
Fundamental Score
Amwill Health Care Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Amwill Health Care Ltd share price today is ₹28.95, down 4.93% on NSE/BSE as of 30 March 2026. Amwill Health Care Ltd (AMWILL) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹85.98 (Cr). The 52-week high for AMWILL share price is ₹104.90 and the 52-week low is ₹30.00. At a P/E ratio of 10.64x, AMWILL is currently trading below its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 24.85% and a debt-to-equity ratio of 0.00.
Amwill Health Care Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Amwill Health Care Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Amwill Health Care Share Price: A ROCE-Focused Analysis
The pharmaceutical sector, a cornerstone of global health, is currently facing margin pressures due to rising raw material costs and increased regulatory scrutiny. Amidst this challenging environment, the Amwill Health Care share price currently stands at ₹34.650002, with a price-to-earnings (PE) ratio of 10.64. This analysis delves into the financial health of Amwill Health Care Ltd, focusing particularly on its Return on Capital Employed (ROCE) efficiency and comparing it to its sector peers.
Amwill Health Care's ROCE of 27.56% is a key indicator of its operational efficiency and profitability. ROCE measures how effectively a company generates profits from its capital employed. A higher ROCE suggests that the company is generating more profit per rupee of capital invested. This superior capital allocation translates to a stronger economic moat, allowing Amwill Health Care to reinvest earnings for further growth and potentially weather economic downturns more effectively than companies with lower ROCE figures. For example, a company like
Mankind Pharma Ltd may have a different strategy regarding operational expenses which directly impacts ROCE values.While PE ratio offers a snapshot of valuation relative to earnings, ROCE provides a deeper understanding of the quality of those earnings. Comparing Amwill Health Care Ltd to peers like Smruthi Organics Ltd and Balaxi Pharmaceuticals Ltd based solely on PE ratio would paint an incomplete picture. A detailed comparison of management quality and operational efficiency, similar to how one might analyze
Mankind Pharma Ltd's operational success, is crucial to truly understanding long-term performance sustainability. The efficient use of capital at Amwill, leading to the higher ROCE, could be indicative of superior management execution.It's important to note that this analysis is part of a comprehensive 80-parameter fundamental audit, verified by Sweta Mishra. The observations presented are based on publicly available data and are intended for informational purposes only. This analysis does not constitute financial advice, and no buy or sell recommendations are being made. Investors should conduct their own thorough research before making any investment decisions.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Amwill Health Care Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of AMWILL across key market metrics for learning purposes.
Positive Indicators
7 factors identified
Strong Return on Equity (24.85%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (27.56%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (23.43%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 10.64 vs Industry: 31.77)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Balanced Promoter Holding (70.65%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
4 factors identified
Profit Decline Concern (-40.64%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-8.42%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Institutional Interest (FII+DII: 1.16%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Amwill Health Care Ltd Financial Statements
Comprehensive financial data for Amwill Health Care Ltd including income statement, balance sheet and cash flow
About AMWILL (Amwill Health Care Ltd)
Amwill Health Care Ltd is a pharmaceutical enterprise dedicated to innovating and delivering advanced healthcare solutions. With a strong commitment to research and development, AM...WILL focuses on creating novel therapeutic interventions and improving existing treatment modalities across various medical disciplines. The company is structured around a multifaceted approach, encompassing the entire lifecycle of pharmaceutical products, from initial discovery and preclinical studies to clinical trials, regulatory approvals, manufacturing, and commercialization. AMWILL's core strength lies in its team of experienced scientists, clinicians, and industry professionals who collaborate to address unmet medical needs and enhance patient outcomes. Through strategic partnerships and a continuous pursuit of scientific excellence, AMWILL strives to be a catalyst for progress in the ever-evolving landscape of healthcare. AMWILL Health Care Ltd distinguishes itself through its state-of-the-art manufacturing facilities and rigorous quality control processes, ensuring that its products consistently meet the highest standards of safety and efficacy. The company's diverse portfolio includes a wide array of pharmaceutical formulations, catering to a broad spectrum of therapeutic areas, including but not limited to, cardiovascular health, oncology, neurology, and infectious diseases. By embracing cutting-edge technologies and adhering to stringent regulatory guidelines, AMWILL ensures that its offerings are not only effective but also accessible to patients worldwide. The company actively invests in building a robust distribution network and fostering strong relationships with healthcare providers, aiming to facilitate the seamless delivery of its products to those who need them most. Amwill Health Care Ltd is dedicated to corporate social responsibility, understanding that its role extends beyond providing medicines to fostering a healthier and more sustainable future. Through various initiatives, AMWILL actively supports community health programs, promotes environmental conservation, and upholds ethical business practices. The company is committed to transparency and accountability in all its operations, striving to earn the trust and respect of its stakeholders. By prioritizing innovation, quality, and social impact, AMWILL aims to be a trusted partner in healthcare, contributing to the well-being of individuals and communities around the globe. Its overarching goal is to transform lives through its commitment to pharmaceutical excellence and responsible corporate citizenship.
Company Details
Key Leadership
Latest News
AMWILL Share Price: Frequently Asked Questions
What is the current share price of Amwill Health Care Ltd (AMWILL)?
As of 30 Mar 2026, 12:06 pm IST, Amwill Health Care Ltd share price is ₹28.95. The AMWILL stock has a market capitalisation of ₹85.98 (Cr) on NSE/BSE.
Is AMWILL share price Overvalued or Undervalued?
AMWILL share price is currently trading at a P/E ratio of 10.64x, compared to the industry average of 31.77x. Based on this relative valuation, the Amwill Health Care Ltd stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of AMWILL share price?
The 52-week high of AMWILL share price is ₹104.90 and the 52-week low is ₹30.00. These values are updated daily from NSE/BSE price data.
What factors affect the Amwill Health Care Ltd share price?
Key factors influencing AMWILL share price include quarterly earnings growth (Sales Growth: -8.42%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Amwill Health Care Ltd a good stock for long-term investment?
Amwill Health Care Ltd shows a 5-year Profit Growth of N/A% and an ROE of 24.85%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing in AMWILL shares.
How does Amwill Health Care Ltd compare with its industry peers?
Amwill Health Care Ltd competes with major peers in the Pharmaceuticals. Investors should compare AMWILL share price P/E of 10.64x and ROE of 24.85% against the industry averages to determine competitive standing.
What is the P/E ratio of AMWILL and what does it mean?
AMWILL share price has a P/E ratio of 10.64x compared to the industry average of 31.77x. Investors pay ₹11 for every ₹1 of annual earnings.
How is AMWILL performing according to Bull Run's analysis?
AMWILL has a Bull Run fundamental score of 36.2/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does AMWILL belong to?
AMWILL operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Amwill Health Care Ltd share price.
What is Return on Equity (ROE) and why is it important for AMWILL?
AMWILL has an ROE of 24.85%, which indicates excellent management efficiency. ROE measures how efficiently Amwill Health Care Ltd generates profits from shareholders capital.
How is AMWILL debt-to-equity ratio and what does it indicate?
AMWILL has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk.
What is AMWILL dividend yield and is it a good dividend stock?
AMWILL offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Amwill Health Care Ltd shares.
How has AMWILL share price grown over the past 5 years?
AMWILL has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in AMWILL and why does it matter?
Promoters hold 70.65% of AMWILL shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Amwill Health Care Ltd.
What is AMWILL market capitalisation category?
AMWILL has a market capitalisation of ₹86 crores, placing it in the Small-cap category.
How volatile is AMWILL stock?
AMWILL has a beta of N/A. A beta > 1 suggests the Amwill Health Care Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is AMWILL operating profit margin trend?
AMWILL has a 5-year average Operating Profit Margin (OPM) of 23.43%, indicating the company's operational efficiency.
How is AMWILL quarterly performance?
Recent quarterly performance shows Amwill Health Care Ltd YoY Sales Growth of -8.42% and YoY Profit Growth of -40.64%.
What is the institutional holding pattern in AMWILL?
AMWILL has FII holding of 1.16% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Amwill Health Care Ltd stock.